Literature DB >> 21257758

Signaling to myosin regulatory light chain in sarcomeres.

Kristine E Kamm1, James T Stull.   

Abstract

Myosin regulatory light chain (RLC) phosphorylation in skeletal and cardiac muscles modulates Ca(2+)-dependent troponin regulation of contraction. RLC is phosphorylated by a dedicated Ca(2+)-dependent myosin light chain kinase in fast skeletal muscle, where biochemical properties of RLC kinase and phosphatase converge to provide a biochemical memory for RLC phosphorylation and post-activation potentiation of force development. The recent identification of cardiac-specific myosin light chain kinase necessary for basal RLC phosphorylation and another potential RLC kinase (zipper-interacting protein kinase) provides opportunities for new approaches to study signaling pathways related to the physiological function of RLC phosphorylation and its importance in cardiac muscle disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257758      PMCID: PMC3060548          DOI: 10.1074/jbc.R110.198697

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

Review 1.  The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.

Authors:  J G Seidman; C Seidman
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Dedicated myosin light chain kinases with diverse cellular functions.

Authors:  K E Kamm; J T Stull
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation.

Authors:  J S Davis; S Hassanzadeh; S Winitsky; H Lin; C Satorius; R Vemuri; A H Aletras; H Wen; N D Epstein
Journal:  Cell       Date:  2001-11-30       Impact factor: 41.582

4.  Phosphorylation of the regulatory light chains of myosin affects Ca2+ sensitivity of skeletal muscle contraction.

Authors:  Danuta Szczesna; Jiaju Zhao; Michelle Jones; Gang Zhi; James Stull; James D Potter
Journal:  J Appl Physiol (1985)       Date:  2002-04

5.  Kinetic effects of myosin regulatory light chain phosphorylation on skeletal muscle contraction.

Authors:  Julien S Davis; Colleen L Satorius; Neal D Epstein
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

6.  Further insights into calmodulin-myosin light chain kinase interaction from solution scattering and shape restoration.

Authors:  William T Heller; Joanna K Krueger; Jill Trewhella
Journal:  Biochemistry       Date:  2003-09-16       Impact factor: 3.162

Review 7.  Postactivation potentiation: role in human performance.

Authors:  Digby G Sale
Journal:  Exerc Sport Sci Rev       Date:  2002-07       Impact factor: 6.230

8.  Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation.

Authors:  D Szczesna; D Ghosh; Q Li; A V Gomes; G Guzman; C Arana; G Zhi; J T Stull; J D Potter
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

9.  Activation of myosin light chain kinase requires translocation of bound calmodulin.

Authors:  J K Krueger; S C Gallagher; G Zhi; R Geguchadze; A Persechini; J T Stull; J Trewhella
Journal:  J Biol Chem       Date:  2000-12-20       Impact factor: 5.157

10.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

View more
  55 in total

1.  Myosin light chain phosphorylation to the rescue.

Authors:  Henk L Granzier; Pieter P de Tombe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-08       Impact factor: 11.205

2.  Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo.

Authors:  Audrey N Chang; Pavan K Battiprolu; Patrick M Cowley; Guohua Chen; Robert D Gerard; Jose R Pinto; Joseph A Hill; Anthony J Baker; Kristine E Kamm; James T Stull
Journal:  J Biol Chem       Date:  2015-03-02       Impact factor: 5.157

Review 3.  Targeting the sarcomere to correct muscle function.

Authors:  Peter M Hwang; Brian D Sykes
Journal:  Nat Rev Drug Discov       Date:  2015-04-17       Impact factor: 84.694

Review 4.  Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor.

Authors:  Jeffrey R Moore; Leslie Leinwand; David M Warshaw
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

5.  The kinase domains of obscurin interact with intercellular adhesion proteins.

Authors:  Li-Yen R Hu; Aikaterini Kontrogianni-Konstantopoulos
Journal:  FASEB J       Date:  2013-02-07       Impact factor: 5.191

6.  Physiological contractility of cardiomyocytes in the wall of mouse and rat azygos vein.

Authors:  Rong Liu; Han-Zhong Feng; J-P Jin
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-29       Impact factor: 4.249

Review 7.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

Review 8.  Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations.

Authors:  Wenrui Huang; Danuta Szczesna-Cordary
Journal:  J Muscle Res Cell Motil       Date:  2015-09-18       Impact factor: 2.698

9.  Estradiol modulates myosin regulatory light chain phosphorylation and contractility in skeletal muscle of female mice.

Authors:  Shaojuan Lai; Brittany C Collins; Brett A Colson; Georgios Kararigas; Dawn A Lowe
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-08       Impact factor: 4.310

10.  Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.

Authors:  Wenrui Huang; Jingsheng Liang; Katarzyna Kazmierczak; Priya Muthu; Divya Duggal; Gerrie P Farman; Lars Sorensen; Iraklis Pozios; Theodore P Abraham; Jeffrey R Moore; Julian Borejdo; Danuta Szczesna-Cordary
Journal:  J Mol Cell Cardiol       Date:  2014-06-30       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.